MeiraGTx/$MGTX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MeiraGTx
MeiraGTx Holdings PLC is a clinical-stage gene therapy company. It focuses on the eye, salivary gland, and central nervous system disorders. The company's pipeline products include AAV-CNGB3, AAV-CNGA3 and AAV-RPGR, and others. Geographically, it operates in the United States, the United Kingdom, and European Union.
Ticker
$MGTX
Sector
Trading on
Industry
Biotechnology
Headquarters
Employees
372
ISIN
KYG596651029
Website
MeiraGTx Metrics
BasicAdvanced
$431M
-
-$2.27
1.31
-
Price and volume
Market cap
$431M
Beta
1.31
52-week high
$8.75
52-week low
$3.85
Average daily volume
570K
Financial strength
Current ratio
1.525
Quick ratio
1.37
Long term debt to equity
234.391
Total debt to equity
244.352
Interest coverage (TTM)
-12.17%
Management effectiveness
Return on assets (TTM)
-37.28%
Return on equity (TTM)
-216.14%
Valuation
Price to revenue (TTM)
11.426
Price to book
12.86
Price to tangible book (TTM)
13.17
Price to free cash flow (TTM)
-3.599
Growth
Revenue change (TTM)
203.23%
Earnings per share change (TTM)
84.70%
3-year revenue growth (CAGR)
-3.78%
3-year earnings per share growth (CAGR)
5.00%
What the Analysts think about MeiraGTx
Analyst ratings (Buy, Hold, Sell) for MeiraGTx stock.
MeiraGTx Financial Performance
Revenues and expenses
MeiraGTx Earnings Performance
Company profitability
MeiraGTx News
AllArticlesVideos
MeiraGTx Announces the Presentation of Four Posters at the American Society of Gene and Cell Therapy (ASGCT) 2025 Annual Meeting
GlobeNewsWire·2 weeks ago
MeiraGTx Reports First Quarter 2025 Financial and Operational Results
GlobeNewsWire·2 weeks ago
MeiraGTx Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for AAV-GAD for the Treatment of Parkinson's Disease
GlobeNewsWire·3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for MeiraGTx stock?
MeiraGTx (MGTX) has a market cap of $431M as of May 30, 2025.
What is the P/E ratio for MeiraGTx stock?
The price to earnings (P/E) ratio for MeiraGTx (MGTX) stock is 0 as of May 30, 2025.
Does MeiraGTx stock pay dividends?
No, MeiraGTx (MGTX) stock does not pay dividends to its shareholders as of May 30, 2025.
When is the next MeiraGTx dividend payment date?
MeiraGTx (MGTX) stock does not pay dividends to its shareholders.
What is the beta indicator for MeiraGTx?
MeiraGTx (MGTX) has a beta rating of 1.31. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.